Bloomberg News is reporting that drug maker, AstraZeneca has concealed unfavorable studies linking the prescription drug Seroquel to Diabetes. Emails turned over as part of litigation related to the drug Seroquel have revealed that AstraZeneca “buried” studies with bad outcomes.
More than 15,000 people have filed lawsuits claiming the drug maker failed to warn its users of the connection between the antipsychotic drug and diabetes. These lawsuits also claim that AstraZeneca promoted off label uses for the drug beyond the purpose for which the drug was approved by the FDA.
The first Seroquel trial is set to begin in April in Deleware state court.